4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-002877
Options or other derivatives
- SVP, General Counsel acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Oltmans Curtis Gale SVP, General Counsel | 2022-01-19 | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | D | ||
Loading xslF345X03/doc4.xml…